{"id":"n_unicwofbrv2sgeevgdbq","seq":12323980,"kind":"article","title":"Biocon gets US FDA approval for Pebrilzo™ Injection, biosimilar to Perjeta®, expanding oncology portfolio","url":"https://www.biospectrumindia.com/news/104/28835/biocon-gets-us-fda-approval-for-pebrilzo-injection-biosimilar-to-perjeta-expanding-oncology-portfolio.html","published":"2026-11-18T05:07:00Z","seen":"2026-11-18T05:07:00Z","lang":"en","source":{"id":"biospectrumindia.com","name":"biospectrumindia.com","domain":"biospectrumindia.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q29006332","name":"Perjeta","type":"other"}],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.38,"category2":"economy-business","sentiment":"positive","tone":0.44,"political":0.17}